Tag: luminalB

Luminal B breast cancer: Breast cancer that is weakly to moderately ER+ and PR+. Can be HER2- or HER2+. May have low tumor grade, but with higher proliferation and DNA instability than luminal A. ER+/PR- and ER-/PR+ tumors are normally luminal B.

Articles

News

09/17/17
KI-67 proliferation index linked to survival in women with luminal breast cancer
07/22/17
ER+ breast cancer can have worse prognosis than ER- disease in young women
12/31/16
High-fat soybean oil diet promotes metastasis in mouse model of ER+/PR+ breast cancer
01/20/13
Triple negative and some HER2+ subtypes have up to 11% rate of locoregional recurrence after mastectomy
06/25/12
Lobular breast cancer has less favorable prognosis than expected
05/17/12
Metformin reduces cancer proliferation, but only in those with insulin resistance
03/22/12
Animal model of ER+/PR+ breast cancer shows that estrogen fuels recurrence
11/05/11
Luminal breast cancer prognosis can vary based on other tumor characteristics
10/20/11
Age and breast cancer subtype influence prognosis after lumpectomy
10/13/11
Coexisting DCIS independently predicts lower tumor aggressiveness in luminal breast cancer
09/22/11
Herceptin has reduced locoregional recurrence for HER2+ compared to triple negative breast cancer
09/18/11
Different breast cancer subtypes are prone to metastasize to different sites in the body
08/01/11
Breast cancer subtype influences prognosis after neoadjuvant chemotherapy
03/30/11
Although similar, ER+/PR- breast cancer is more aggressive than ER+/PR+
01/18/10
Oral contraceptive use at young age increases risk of triple negative breast cancer

Studies




Breast cancer resources | Definitions | Selected supplements and vitamins | Privacy policy | Search | Tags | Disclaimer/about us | Make a donation | Sitemap